REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 459 filers reported holding REPLIGEN CORP in Q1 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $307,650,322 | +116.1% | 1,945,338 | +92.2% | 0.69% | +20.1% |
Q2 2023 | $142,372,558 | -1.9% | 1,012,067 | +16.8% | 0.57% | -5.6% |
Q1 2023 | $145,075,980 | +4.9% | 866,379 | +5.5% | 0.61% | -1.9% |
Q4 2022 | $138,233,827 | -1.5% | 820,852 | +8.9% | 0.62% | -14.4% |
Q3 2022 | $140,387,000 | +2.2% | 754,101 | -11.3% | 0.72% | +7.8% |
Q2 2022 | $137,377,000 | -17.8% | 850,151 | -4.8% | 0.67% | -3.0% |
Q1 2022 | $167,227,000 | -22.0% | 893,311 | +9.9% | 0.69% | -11.9% |
Q4 2021 | $214,295,000 | +20.6% | 813,012 | +31.6% | 0.78% | +7.4% |
Q3 2021 | $177,619,000 | +9.5% | 617,712 | -24.3% | 0.73% | +2.1% |
Q2 2021 | $162,229,000 | +9.5% | 816,516 | +6.6% | 0.72% | -5.7% |
Q1 2021 | $148,204,000 | +38.7% | 766,154 | +36.6% | 0.76% | +11.5% |
Q4 2020 | $106,817,000 | +156.5% | 560,848 | +96.7% | 0.68% | +86.8% |
Q3 2020 | $41,638,000 | +16.7% | 285,137 | -1.2% | 0.36% | -0.5% |
Q2 2020 | $35,673,000 | +129.2% | 288,596 | +76.9% | 0.37% | +76.8% |
Q1 2020 | $15,563,000 | – | 163,100 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |